BIOMAT Database Logo BIOMAT Database Logo

Update on Turner and Noonan syndromes. 2012

Elizabeth Chacko, and Evan Graber, and Molly O Regelmann, and Elizabeth Wallach, and Gertrude Costin, and Robert Rapaport
Division of Pediatric Endocrinology and Diabetes, Mount Sinai School of Medicine, New York, NY 10029, USA.

Turner syndrome (TS) and Noonan syndrome (NS) have short stature as a constant feature; however, both conditions can present clinicians with a challenging array of genetic, cardiovascular, developmental, and psychosocial issues. In recent years, important advances have been achieved in each of these areas. This article reviews these two syndromes and provides updates on recent developments in diagnostic evaluation, growth and development, psychological issues, and treatment options for patients with TS and NS.

UI MeSH Term Description Entries
D008297 Male Males
D009634 Noonan Syndrome A genetically heterogeneous, multifaceted disorder characterized by short stature, webbed neck, ptosis, skeletal malformations, hypertelorism, hormonal imbalance, CRYPTORCHIDISM, multiple cardiac abnormalities (most commonly including PULMONARY VALVE STENOSIS), and some degree of INTELLECTUAL DISABILITY. The phenotype bears similarities to that of TURNER SYNDROME that occurs only in females and has its basis in a 45, X karyotype abnormality. Noonan syndrome occurs in both males and females with a normal karyotype (46,XX and 46,XY). Mutations in a several genes (PTPN11, KRAS, SOS1, NF1 and RAF1) have been associated the NS phenotype. Mutations in PTPN11 are the most common. LEOPARD SYNDROME, a disorder that has clinical features overlapping those of Noonan Syndrome, is also due to mutations in PTPN11. In addition, there is overlap with the syndrome called neurofibromatosis-Noonan syndrome due to mutations in NF1. Male Turner Syndrome,Turner Syndrome, Male,Familial Turner Syndrome,Female Pseudo-Turner Syndrome,Noonan Syndrome 1,Noonan-Ehmke Syndrome,Pseudo-Ullrich-Turner Syndrome,Turner Phenotype with Normal Karyotype,Turner's Phenotype, Karyotype Normal,Turner's Syndrome, Male,Turner-Like Syndrome,Ullrich-Noonan Syndrome,Female Pseudo Turner Syndrome,Male Turner's Syndrome,Noonan Ehmke Syndrome,Pseudo Ullrich Turner Syndrome,Pseudo-Turner Syndrome, Female,Turner Like Syndrome,Turner Syndrome, Familial,Ullrich Noonan Syndrome
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005260 Female Females
D006130 Growth Disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth. Stunted Growth,Stunting,Disorder, Growth,Growth Disorder,Growth, Stunted,Stuntings
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin
D014424 Turner Syndrome A syndrome of defective gonadal development in phenotypic females associated with the karyotype 45,X (or 45,XO). Patients generally are of short stature with undifferentiated GONADS (streak gonads), SEXUAL INFANTILISM, HYPOGONADISM, webbing of the neck, cubitus valgus, elevated GONADOTROPINS, decreased ESTRADIOL level in blood, and CONGENITAL HEART DEFECTS. NOONAN SYNDROME (also called Pseudo-Turner Syndrome and Male Turner Syndrome) resembles this disorder; however, it occurs in males and females with a normal karyotype and is inherited as an autosomal dominant. Bonnevie-Ullrich Syndrome,Gonadal Dysgenesis, 45,X,Gonadal Dysgenesis, XO,Monosomy X,Status Bonnevie-Ullrich,Turner's Syndrome,Ullrich-Turner Syndrome,Bonnevie Ullrich Syndrome,Status Bonnevie Ullrich,Syndrome, Ullrich-Turner,Turners Syndrome,Ullrich Turner Syndrome,XO Gonadal Dysgenesis
D016649 Primary Ovarian Insufficiency Cessation of ovarian function after MENARCHE but before the age of 40, without or with OVARIAN FOLLICLE depletion. It is characterized by the presence of OLIGOMENORRHEA or AMENORRHEA, elevated GONADOTROPINS, and low ESTRADIOL levels. It is a state of female HYPERGONADOTROPIC HYPOGONADISM. Etiologies include genetic defects, autoimmune processes, chemotherapy, radiation, and infections. The most commonly known genetic cause is the expansion of a CGG repeat to 55 to 199 copies in the 5' untranslated region in the X-linked FMR1 gene. Gonadotropin-Resistant Ovary Syndrome,Ovarian Failure, Premature,Resistant Ovary Syndrome,FMR1-Related Primary Ovarian Insufficiency,Fragile X Premature Ovarian Failure,Fragile X-Associated Primary Ovarian Insufficiency,Hypergonadotropic Ovarian Failure, X-Linked,Premature Ovarian Failure,Premature Ovarian Failure 1,Premature Ovarian Failure, X-Linked,Primary Ovarian Insufficiency, Fragile X-Associated,X-Linked Hypergonadotropic Ovarian Failure,FMR1 Related Primary Ovarian Insufficiency,Fragile X Associated Primary Ovarian Insufficiency,Gonadotropin Resistant Ovary Syndrome,Hypergonadotropic Ovarian Failure, X Linked,Ovarian Insufficiency, Primary,Premature Ovarian Failure, X Linked,Primary Ovarian Insufficiency, Fragile X Associated,X Linked Hypergonadotropic Ovarian Failure

Related Publications

Elizabeth Chacko, and Evan Graber, and Molly O Regelmann, and Elizabeth Wallach, and Gertrude Costin, and Robert Rapaport
Short stature and its treatment in Turner and Noonan syndromes.
February 2012, Current opinion in endocrinology, diabetes, and obesity,
Elizabeth Chacko, and Evan Graber, and Molly O Regelmann, and Elizabeth Wallach, and Gertrude Costin, and Robert Rapaport
Syndrome-Specific Neuroanatomical Phenotypes in Girls With Turner and Noonan Syndromes.
February 2024, Biological psychiatry. Cognitive neuroscience and neuroimaging,
Elizabeth Chacko, and Evan Graber, and Molly O Regelmann, and Elizabeth Wallach, and Gertrude Costin, and Robert Rapaport
The illusion of widely spaced nipples in the Noonan and the Turner syndromes.
October 1973, The Journal of pediatrics,
Elizabeth Chacko, and Evan Graber, and Molly O Regelmann, and Elizabeth Wallach, and Gertrude Costin, and Robert Rapaport
Alexithymia, emotion perception, and social assertiveness in adult women with Noonan and Turner syndromes.
April 2015, American journal of medical genetics. Part A,
Elizabeth Chacko, and Evan Graber, and Molly O Regelmann, and Elizabeth Wallach, and Gertrude Costin, and Robert Rapaport
Tegumentary manifestations of Noonan and Noonan-related syndromes.
January 2013, Clinics (Sao Paulo, Brazil),
Elizabeth Chacko, and Evan Graber, and Molly O Regelmann, and Elizabeth Wallach, and Gertrude Costin, and Robert Rapaport
Growing news on Noonan and related syndromes.
December 2009, Hormone research,
Elizabeth Chacko, and Evan Graber, and Molly O Regelmann, and Elizabeth Wallach, and Gertrude Costin, and Robert Rapaport
[Andrological results in Turner-Noonan syndrome].
January 1982, Andrologia,
Elizabeth Chacko, and Evan Graber, and Molly O Regelmann, and Elizabeth Wallach, and Gertrude Costin, and Robert Rapaport
The Ullrich-Noonan syndrome (Turner phenotype).
January 1974, American journal of diseases of children (1960),
Elizabeth Chacko, and Evan Graber, and Molly O Regelmann, and Elizabeth Wallach, and Gertrude Costin, and Robert Rapaport
[Klinefelter and Turner syndromes].
October 1959, Minerva medica,
Elizabeth Chacko, and Evan Graber, and Molly O Regelmann, and Elizabeth Wallach, and Gertrude Costin, and Robert Rapaport
Noonan syndrome: an update on growth and development.
February 2018, Current opinion in endocrinology, diabetes, and obesity,
Copied contents to your clipboard!